Biotron Ltd (ASX: BIT) Share Price and News

Price

$0.003

Movement

0.00 (0.0)

as at 7 May - Closed (20 mins delayed)

52 Week Range

$0.002 - $0.066

 
1 Year Return

-95.0%

Biotron Ltd Chart and Price Data

2025
2025
2025
2025
$0.00
$0.02
$0.04
$0.00
$0.02
$0.04
$0.00
$0.02
$0.04
$0.00
$0.02
$0.04

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $3.98 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 1.33 billion
Earnings per share -0.001
Dividend per share N/A
Year To Date Return -80.95%
Earnings Yield N/A
Franking -
Share Price

$0.003

Day Change

0.00 (0.0)

52 Week Range

$0.002 - $0.066

Yesterday's Close

$0.003

Today's Open

$0.003

Days Range

$0.003 - $0.003

Volume

205,761

Avg. Volume (1 month)

2,478,237

Turnover

$617

as at 7 May - Closed

  • Should you invest $1,000 in Biotron Limited right now?

    Before you buy Biotron Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Biotron Limited wasn't one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys...

    See The 5 Stocks *Returns as of 30 April 2025

  • Biotron Ltd (ASX: BIT)
    Latest News

    a woman
    Share Gainers

    These small cap ASX shares have surged higher on Thursday

    The Biotron Limited (ASX:BIT) share price has rocketed higher along with two other small caps on Thursday despite the market…

    Read more »

    a woman
    Share Fallers

    Biotron Limited (ASX:BIT) shares sank 27% lower on Wednesday

    The Biotron Limited (ASX:BIT) share price was smashed on Wednesday and sank 27% lower. Here's what you need to know...

    Read more »

    a woman
    Share Fallers

    Why these 4 ASX shares have started the week in the red

    The Flight Centre Travel Group Ltd (ASX:FLT) share price is one of four starting the week in the red. Here's…

    Read more »

    a woman
    Share Gainers

    The Biotron Limited (ASX:BIT) share price jumped 70% higher this week

    Biotron Limited (ASX:BIT) shares have been on fire this week. Here's what you need to know...

    Read more »

    a woman
    Share Gainers

    These 3 small cap ASX shares are ending the week on a high

    The AVZ Minerals Ltd (ASX:AVZ) share price is one of three on the rise at the small end of the…

    Read more »

    a woman
    Share Gainers

    These 3 ASX shares are pushing higher on Wednesday

    The Biotron Limited (ASX:BIT) share price is one of three at the small end of the market pushing higher on…

    Read more »

    a woman
    Share Gainers

    Why these 4 ASX shares have started the week with a bang

    The Biotron Limited (ASX:BIT) share price is one of four starting the week with a bang on Monday. Here's why...

    Read more »

    a woman
    Record Highs

    The Biotron Limited (ASX:BIT) share price is up 800% in just two weeks

    The Biotron Limited (ASX:BIT) share price has rocketed a remarkable 800% in just two weeks. Is this the real deal?

    Read more »

    a woman
    Share Market News

    These 3 ASX small cap shares have stormed higher on Thursday

    The Biotron Limited (ASX:BIT) share price is one of three storming higher at the small end of the market on…

    Read more »

    a woman
    Share Gainers

    These 3 small cap ASX shares are posting strong gains on Wednesday

    The Biotron Limited (ASX:BIT) share price is one of three at the small end of the market posting strong gains…

    Read more »

    a woman
    Share Gainers

    These 3 small cap ASX shares are on the rise on Tuesday

    The Biotron Limited (ASX:BIT) share price is one of three on the rise at the small end of the market…

    Read more »

    a woman
    Investing

    5 of the best companies presenting at Australia Biotech Invest 2014

    If you’re looking for some high-risk/high-reward investment ideas, Australia’s biotechnology scene could be on the verge of a lot of…

    Read more »

    BIT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    2nd May 2025 2025-05-02T13:52:47 Company Secretary Appointment/ResignationYesNo1:52pm141k
    24th Apr 2025 2025-04-24T09:07:48 Quarterly Activities/Appendix 4C Cash Flow ReportYesNo9:07am7358k
    10th Apr 2025 2025-04-10T10:15:34 Change of Director's Interest NoticeYesNo10:15am7276k
    8th Apr 2025 2025-04-08T09:07:46 Application for quotation of securities - BITYesNo9:07am616k
    8th Apr 2025 2025-04-08T09:06:51 Rights Issue ClosedYesNo9:06am2137k
    18th Mar 2025 2025-03-18T11:34:16 Dispatch of Rights Issue Offer documentsYesNo11:34am2264k
    13th Mar 2025 2025-03-13T09:32:45 Update on Rights Issue TimetableYesNo9:32am2165k
    13th Mar 2025 2025-03-13T08:31:55 Update - Proposed issue of securities - BITYesNo8:31am621k
    12th Mar 2025 2025-03-12T17:23:25 Replacement ProspectusYesNo5:23pm43395k
    12th Mar 2025 2025-03-12T13:46:54 Response to ASX Query LetterYesNo1:46pm9383k

    About Biotron Ltd

    Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.

    BIT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    06 May 2025 $0.00 $0.00 0.00% 418,979 $0.00 $0.00 $0.00
    05 May 2025 $0.00 $0.00 0.00% 420,056 $0.00 $0.00 $0.00
    02 May 2025 $0.00 $0.00 0.00% 3,405,849 $0.00 $0.00 $0.00
    01 May 2025 $0.00 $0.00 0.00% 321,000 $0.00 $0.00 $0.00
    30 Apr 2025 $0.00 $0.00 0.00% 458,025 $0.00 $0.00 $0.00
    29 Apr 2025 $0.00 $0.00 0.00% 1,131,399 $0.00 $0.00 $0.00
    28 Apr 2025 $0.00 $0.00 0.00% 341,722 $0.00 $0.00 $0.00
    24 Apr 2025 $0.00 $0.00 0.00% 561,750 $0.00 $0.00 $0.00
    22 Apr 2025 $0.00 $0.00 0.00% 178,065 $0.00 $0.00 $0.00
    17 Apr 2025 $0.00 $0.00 0.00% 3,745,716 $0.00 $0.00 $0.00
    16 Apr 2025 $0.00 $0.00 0.00% 533,333 $0.00 $0.00 $0.00
    15 Apr 2025 $0.00 $0.00 0.00% 1,520,250 $0.00 $0.00 $0.00
    14 Apr 2025 $0.00 $0.00 0.00% 1,602,975 $0.00 $0.00 $0.00
    11 Apr 2025 $0.00 $0.00 0.00% 10,000,000 $0.00 $0.00 $0.00
    10 Apr 2025 $0.00 $0.00 0.00% 19,716,108 $0.00 $0.00 $0.00
    09 Apr 2025 $0.00 $0.00 0.00% 280,000 $0.00 $0.00 $0.00
    08 Apr 2025 $0.00 $0.00 0.00% 234,531 $0.00 $0.00 $0.00

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    08 Apr 2025 Michael Hoy Issued 11,217,353 $33,652
    Rights issue.
    08 Apr 2025 Robert Thomas Issued 4,200,000 $12,600
    Rights issue.
    08 Apr 2025 Michelle Miller Issued 1,987,500 $5,962
    Rights issue.
    08 Apr 2025 Michelle Miller Issued 1,800,000 $5,400
    Rights issue.
    25 Nov 2024 Michael Hoy Expiry 934,780 $17,760
    Options expired.
    25 Nov 2024 Michelle Miller Expiry 315,000 $5,985
    Options expired. As per announcement on 28-11-2024
    25 Nov 2024 Robert Thomas Expiry 268,403 $5,099
    Options expired.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Michael J Hoy Non-Executive DirectorNon-Executive Chairman Feb 2000
    Mr Hoy has more than 30 years of corporate experience in Australia, the United Kingdom, USA and Asia. He is Chairman of Lipotek Pty Limited and a former director of John Fairfax Holdings Limited and FXF Trust.
    Mr Robert Bain Thomas Non-Executive Director Mar 2012
    Mr Thomas has over 35 years of experience in the securities industry, with Potter Partners (now UBS), County NatWest and Citigroup. He is the chairman of Starpharma Holdings Limited and a director of Clarity Pharmaceuticals Limited. He chairs Grahger Securities Pty Ltd and is a director of O'Connell Street Associates Pty Limited.
    Dr Michelle Miller Managing Director Jun 2002
    Dr Miller has worked for over 25 years in the bioscience industry, with experience in commercial drug development. Her experience includes several years at Johnson & Johnson developing anti-HIV gene therapeutics through preclinical research to clinical trials. She has finance industry experience from time spent as an Investment Manager with a specialist bioscience venture capital fund.
    Mr Marcelo Mora Company Secretary May 2025
    -
    Marcelo Mora Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Rookharp Capital Pty Limited 26,920,201 2.98%
    Jey Investment Pty Ltd 24,240,000 2.69%
    Umbiram Pty Ltd <Michael Hoy Superfund A/C> 11,217,352 1.24%
    Fordholm Investments Pty Ltd <Fordholm Super Fund A/C> 10,300,000 1.14%
    Citicorp Nominees Pty Limited 10,201,698 1.13%
    Dr Angela Fay Dulhunty 10,000,000 1.11%
    Dr Huy Tran 9,699,357 1.07%
    Dns Accounting And Law Consultancy Pty Ltd 8,359,582 0.93%
    Attollo Copia Pty Ltd <F A Pires Super Fund A/C> 7,620,678 0.84%
    Pathold No 222 Pty Ltd 7,600,000 0.84%
    Armco Barriers Pty Ltd 7,550,000 0.84%
    Mr William John Dunn 7,300,000 0.81%
    Edstop Pty Limited <Superannuation Fund A/C> 6,045,906 0.67%
    Standby Forty Six Pty Limited 5,600,000 0.62%
    Vicex Holdings Proprietary Limited <Vicex Super A/C> 5,600,000 0.62%
    Scotts A V Pty Ltd <Scotts Acorn Emp S/F A/C> 4,918,000 0.55%
    Mr Travis Paul Gloury 4,819,355 0.53%
    Mr Charles Tollios Panos 4,338,928 0.48%
    Mr Peter James Nightingale 4,313,884 0.48%
    Mr Mark Andrew Peterson 4,263,157 0.48%

    Profile

    since

    Note